(1)連結財政状態計算書

(単位:百万円)

 

 

前連結会計年度
(2025年3月31日)

 

当連結会計年度
(2026年3月31日)

資産

 

 

 

 

流動資産

 

 

 

 

現金及び現金同等物

 

209,838

 

208,589

営業債権及びその他の債権

 

593,836

 

608,670

その他の金融資産

 

45,015

 

47,551

棚卸資産

 

625,243

 

595,471

その他の流動資産

 

49,993

 

47,429

小計

 

1,523,925

 

1,507,710

売却目的で保有する資産

 

59,209

 

流動資産合計

 

1,583,134

 

1,507,710

非流動資産

 

 

 

 

有形固定資産

 

759,266

 

770,688

のれん

 

257,811

 

275,711

無形資産

 

239,319

 

225,334

持分法で会計処理されている
投資

 

287,977

 

203,862

その他の金融資産

 

177,405

 

301,222

退職給付に係る資産

 

72,618

 

52,222

繰延税金資産

 

34,608

 

39,227

その他の非流動資産

 

27,646

 

29,065

非流動資産合計

 

1,856,650

 

1,897,331

資産合計

 

3,439,784

 

3,405,041

 

 

 

 

 

 

 

(単位:百万円)

 

 

前連結会計年度
(2025年3月31日)

 

当連結会計年度
(2026年3月31日)

負債及び資本

 

 

 

 

負債

 

 

 

 

流動負債

 

 

 

 

社債及び借入金

 

252,892

 

241,422

営業債務及びその他の債務

 

488,132

 

464,422

その他の金融負債

 

81,364

 

63,737

未払法人所得税等

 

10,627

 

7,022

引当金

 

89,711

 

110,408

その他の流動負債

 

109,360

 

114,335

小計

 

1,032,086

 

1,001,346

売却目的で保有する資産に
直接関連する負債

 

6,661

 

流動負債合計

 

1,038,747

 

1,001,346

非流動負債

 

 

 

 

社債及び借入金

 

1,033,236

 

910,033

その他の金融負債

 

91,157

 

87,885

退職給付に係る負債

 

24,841

 

22,084

引当金

 

25,974

 

26,383

繰延税金負債

 

111,048

 

78,321

その他の非流動負債

 

40,366

 

42,316

非流動負債合計

 

1,326,622

 

1,167,022

負債合計

 

2,365,369

 

2,168,368

資本

 

 

 

 

資本金

 

90,059

 

90,179

資本剰余金

 

 

1,966

利益剰余金

 

640,611

 

655,384

自己株式

 

8,361

 

2,650

その他の資本の構成要素

 

174,871

 

263,765

売却目的で保有する資産に関連する
その他の包括利益

 

3,610

 

親会社の所有者に帰属する持分
合計

 

900,790

 

1,008,644

非支配持分

 

173,625

 

228,029

資本合計

 

1,074,415

 

1,236,673

負債及び資本合計

 

3,439,784

 

3,405,041

 

 

 

 

 

 

 

E00752 40050 住友化学株式会社 SUMITOMO CHEMICAL COMPANY, LIMITED 通期第3号参考様式 [IFRS](連結) IFRS true cte cte 2025-04-01 2026-03-31 FY 2026-03-31 2024-04-01 2025-03-31 2025-03-31 1 false false false 40050 2026-05-14 40050 2025-04-01 2026-03-31 40050 2025-04-01 2026-03-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2025-04-01 2026-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2025-04-01 2026-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2025-04-01 2026-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2025-04-01 2026-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2025-04-01 2026-03-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2025-04-01 2026-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 40050 2025-04-01 2026-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2025-04-01 2026-03-31 jpcrp_cor:ReconcilingItemsMember 40050 2025-04-01 2026-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2025-04-01 2026-03-31 jpcrp_cor:ReportableSegmentsMember 40050 2025-04-01 2026-03-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2025-04-01 2026-03-31 jpigp_cor:ShareCapitalIFRSMember 40050 2025-04-01 2026-03-31 jpigp_cor:TreasurySharesIFRSMember 40050 2025-04-01 2026-03-31 tse-acediffr-40050:EnergyAndFunctionalMaterialsReportableSegmentMember 40050 2025-04-01 2026-03-31 tse-acediffr-40050:EssentialChemicalsAndPlasticsReportableSegmentMember 40050 2025-04-01 2026-03-31 tse-acediffr-40050:HealthAndAgricultureRelatedReportableSegmentMember 40050 2025-04-01 2026-03-31 tse-acediffr-40050:InformationElectronicChemistryReportableSegmentMember 40050 2025-04-01 2026-03-31 tse-acediffr-40050:MedicalProductsReportableSegmentMember 40050 2025-04-01 2026-03-31 tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2026-03-31 40050 2026-03-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2026-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2026-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2026-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2026-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2026-03-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2026-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 40050 2026-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2026-03-31 jpcrp_cor:ReconcilingItemsMember 40050 2026-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2026-03-31 jpcrp_cor:ReportableSegmentsMember 40050 2026-03-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2026-03-31 jpigp_cor:ShareCapitalIFRSMember 40050 2026-03-31 jpigp_cor:TreasurySharesIFRSMember 40050 2026-03-31 tse-acediffr-40050:EnergyAndFunctionalMaterialsReportableSegmentMember 40050 2026-03-31 tse-acediffr-40050:EssentialChemicalsAndPlasticsReportableSegmentMember 40050 2026-03-31 tse-acediffr-40050:HealthAndAgricultureRelatedReportableSegmentMember 40050 2026-03-31 tse-acediffr-40050:InformationElectronicChemistryReportableSegmentMember 40050 2026-03-31 tse-acediffr-40050:MedicalProductsReportableSegmentMember 40050 2026-03-31 tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2024-04-01 2025-03-31 40050 2024-04-01 2025-03-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2024-04-01 2025-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2024-04-01 2025-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2024-04-01 2025-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2024-04-01 2025-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2024-04-01 2025-03-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2024-04-01 2025-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 40050 2024-04-01 2025-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2024-04-01 2025-03-31 jpcrp_cor:ReconcilingItemsMember 40050 2024-04-01 2025-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2024-04-01 2025-03-31 jpcrp_cor:ReportableSegmentsMember 40050 2024-04-01 2025-03-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2024-04-01 2025-03-31 jpigp_cor:ShareCapitalIFRSMember 40050 2024-04-01 2025-03-31 jpigp_cor:TreasurySharesIFRSMember 40050 2024-04-01 2025-03-31 tse-acediffr-40050:EnergyAndFunctionalMaterialsReportableSegmentMember 40050 2024-04-01 2025-03-31 tse-acediffr-40050:EssentialChemicalsAndPlasticsReportableSegmentMember 40050 2024-04-01 2025-03-31 tse-acediffr-40050:HealthAndAgricultureRelatedReportableSegmentMember 40050 2024-04-01 2025-03-31 tse-acediffr-40050:InformationElectronicChemistryReportableSegmentMember 40050 2024-04-01 2025-03-31 tse-acediffr-40050:MedicalProductsReportableSegmentMember 40050 2024-04-01 2025-03-31 tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2025-03-31 40050 2025-03-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2025-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2025-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2025-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2025-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2025-03-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2025-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 40050 2025-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2025-03-31 jpcrp_cor:ReconcilingItemsMember 40050 2025-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2025-03-31 jpcrp_cor:ReportableSegmentsMember 40050 2025-03-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2025-03-31 jpigp_cor:ShareCapitalIFRSMember 40050 2025-03-31 jpigp_cor:TreasurySharesIFRSMember 40050 2025-03-31 tse-acediffr-40050:EnergyAndFunctionalMaterialsReportableSegmentMember 40050 2025-03-31 tse-acediffr-40050:EssentialChemicalsAndPlasticsReportableSegmentMember 40050 2025-03-31 tse-acediffr-40050:HealthAndAgricultureRelatedReportableSegmentMember 40050 2025-03-31 tse-acediffr-40050:InformationElectronicChemistryReportableSegmentMember 40050 2025-03-31 tse-acediffr-40050:MedicalProductsReportableSegmentMember 40050 2025-03-31 tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2024-03-31 40050 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2024-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2024-03-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 40050 2024-03-31 jpigp_cor:TreasurySharesIFRSMember 40050 2024-03-31 tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember iso4217:JPY iso4217:JPY xbrli:shares xbrli:pure